Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our current drug discovery pipeline is aimed at developing novel treatments for degenerative kidney diseases, chronic inflammatory diseases and cancer.
Location: United Kingdom, Scotland
Employees: 11-50
Total raised: $6.31M
Founded date: 2015
Investors 2
Date | Name | Website |
18.08.2021 | BioGenerat... | biogenerat... |
- | Epidarex C... | epidarex.c... |
Funding Rounds 1
Date | Series | Amount | Investors |
20.06.2016 | Series A | $6.31M | - |
Mentions in press and media 3
Date | Title | Description | Source |
13.09.2023 | Mironid Extends Series A Funding; £35M Raised To Date | Mironid, a Glasgow, UK-based biopharmaceutical company developing small molecule therapeutics, exten... | finsmes.co... |
20.06.2016 | Mironid Closes £4.3M ($6.2M) Series A Financing | GLASGOW, Scotland--(BUSINESS WIRE)--Mironid Ltd, a leader in cell signalling directed drug developme... | citybizlis... |
20.06.2016 | Drug Discovery Company Mironid Closes £4.3M Series A Funding... | Mironid Ltd, a Glasgow, Scotland, UK-based drug discovery company, closed its £4.3m ($6.2m) Series A... | finsmes.co... |